Organogenesis Holdings Inc (ORGO) Q2 2020 Earnings Call Transcript
Simply stated, we believe our second-quarter revenue performance is a direct result of the organization's resilience in the face of these unprecedented challenges and the dedication of our employees to our customers and patients. One, the investment that we've made to expand our sales force over the recent years, strong execution of our commercial strategy and the benefits of our comprehensive portfolio and solutions we offer in the Advanced Wound Care and Surgical & Sports Medicine markets.